GlassScriptPhysician profile
M Nabil Shabeeb
NPI 1770532699
$47,666.09
in general payments reported to CMS, 2019-2025
13 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,948 · 2020: $237 · 2021: $300 · 2022: $5,038 · 2023: $13K · 2024: $25K · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $36K · Food and Beverage: $2,614 · Travel and Lodging: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $36,000.00 |
| Food and Beverage | $2,613.55 |
| Travel and Lodging | $530.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $45,286.30 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $760.07 | 2019-2025 | Ventralight St, Phasix Mesh, Arista |
| W. L. Gore & Associates, INC. | $623.53 | 2022 | |
| Conmed Corporation | $250.98 | 2019-2024 | Airseal |
| Stryker Corporation | $209.00 | 2022 | |
| Ethicon US, LLC | $155.92 | 2019-2025 | Monocryl |
| Medical Device Business Services, INC. | $148.43 | 2019 | |
| Medtronic, INC. | $84.67 | 2021 | |
| Baxter Healthcare | $58.96 | 2023 | Tisseel |
| Tactile Systems Technology INC | $45.14 | 2023 | Flexitouch Plus, Entre Plus |
| Covidien LP | $15.65 | 2019 | |
| Tela Bio, INC. | $15.13 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Shire North American Group INC | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw M Shabeeb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.